Background In the last two decades, mesenchymal stem cells (MSCs) have been pre-
clinically utilized in the treatment of a variety of kinds of diseases including chronic …

Patients with chronic obstructive pulmonary disease (COPD) have chronic, irreversible
airway inflammation; currently, there is no effective or curative treatment and the main goals …

COPD is the most frequent chronic respiratory disease and a leading cause of morbidity and
mortality. The major risk factor for COPD development is cigarette smoke, and the most …

Background COPD is a devastating disease affecting millions worldwide. As disease
pathogenesis includes both chronic pulmonary and systemic inflammation, antiinflammatory …

COPD is a chronic inflammatory and destructive disease characterized by progressive
decline in lung function that can accelerate with aging. Preclinical studies suggest that …

Recent studies have revealed that adult stem cells such as bone marrow-derived cells
contribute to lung tissue regeneration and protection, and thus administration of exogenous …

Chronic obstructive pulmonary disease (COPD) is the most frequent chronic respiratory
disease and a leading cause of morbidity and mortality, worldwide. Given that the foremost …

COPD is characterised by tissue destruction and inflammation. Given the lack of curative
treatments and the progressive nature of the disease, new treatments for COPD are highly …

Chronic obstructive pulmonary disease (COPD), characterized by persistent and not fully
reversible airflow restrictions, is currently one of the most widespread chronic lung diseases …

Chronic obstructive pulmonary disease (COPD) is a respiratory disease that has a major
impact worldwide. The currently-available drugs mainly focus on relieving the symptoms of …